Prospector Partners Has Lowered Its Stake in Opus Bk Irvine Calif (OPB) by $4.65 Million as Stock Declined; As Boston Scientific (BSX) Shares Rose, Boston Partners Has Lifted Stake

Opus Bank (NASDAQ:OPB) Logo

Prospector Partners Llc decreased its stake in Opus Bk Irvine Calif (OPB) by 72.09% based on its latest 2018Q3 regulatory filing with the SEC. Prospector Partners Llc sold 172,300 shares as the company’s stock declined 31.22% with the market. The institutional investor held 66,700 shares of the company at the end of 2018Q3, valued at $1.83 million, down from 239,000 at the end of the previous reported quarter. Prospector Partners Llc who had been investing in Opus Bk Irvine Calif for a number of months, seems to be less bullish one the $770.25M market cap company. The stock decreased 0.70% or $0.15 during the last trading session, reaching $21.36. About 74,853 shares traded. Opus Bank (NASDAQ:OPB) has declined 26.90% since February 10, 2018 and is downtrending. It has underperformed by 26.90% the S&P500. Some Historical OPB News: 29/05/2018 – OPUS GROUP AB (PUBL) OPUS.ST – THE TRANSACTION IS FINANCED THROUGH EXISTING CASH; 24/05/2018 – Opus Group: Opus issues bond of SEK 500 million; 11/05/2018 – OPUS GROUP AB (PUBL) – HAS WON A PUBLIC TENDER AND SIGNED A 9-YEAR VEHICLE INSPECTION CONCESSION IN ARICA, CHILE; 23/04/2018 – Opus Bank Closes Above 50-Day Moving Average: Technicals; 29/05/2018 – Opus Group: Opus acquires two vehicle inspection companies in Argentina; 18/05/2018 – Opus Group: Bulletin from Annual General Meeting 2018; 23/04/2018 – Opus Bank Total Loans Increased $55.8M in 1Q; 16/03/2018 – Snapshot: `Fra Angelico/Opus Operantis’ by Robert Polidori; 22/04/2018 – DJ Opus Bank, Inst Holders, 1Q 2018 (OPB); 06/03/2018 – Opus Expands Agency with the Acquisition of CRG Events

Boston Partners increased its stake in Boston Scientific Corp (BSX) by 4% based on its latest 2018Q3 regulatory filing with the SEC. Boston Partners bought 79,623 shares as the company’s stock rose 0.86% while stock markets declined. The institutional investor held 2.07M shares of the medical and dental instruments company at the end of 2018Q3, valued at $79.80 million, up from 1.99 million at the end of the previous reported quarter. Boston Partners who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $54.23 billion market cap company. The stock increased 0.88% or $0.34 during the last trading session, reaching $39.19. About 6.42 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 44.37% since February 10, 2018 and is uptrending. It has outperformed by 44.37% the S&P500. Some Historical BSX News: 25/04/2018 – BOSTON SCIENTIFIC CORP – QTRLY CARDIAC RHYTHM MANAGEMENT SALES $493 MLN VS $463 MLN REPORTED LAST YEAR; 24/04/2018 – BOSTON SCIENTIFIC – ANNOUNCED ONE-YEAR DATA FROM INTREPID STUDY OF DEEP BRAIN STIMULATION FOR ADVANCED, LEVODOPA-RESPONSIVE PARKINSON’S DISEASE IN U.S; 16/04/2018 – BOSTON SCIENTIFIC CORP – ACQUISITION IS EXPECTED TO BE ACCRETIVE ON AN ADJUSTED BASIS AFTER 2018 AND 2019; 20/03/2018 – Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System; 16/04/2018 – BOSTON SCIENTIFIC-DEAL CONSISTS OF CASH PAYMENT OF $150 MLN, AND UP TO ADDITIONAL $125 MLN IN POTENTIAL CLINICAL & COMMERCIAL MILESTONES OVER 4 YEARS; 21/03/2018 – BOSTON SCIENTIFIC CORP – DEAL OF NXTHERA IS EXPECTED TO BE IMMATERIAL TO BOSTON SCIENTIFIC ADJUSTED EPS THROUGH 2020 AND ACCRETIVE THEREAFTER; 05/03/2018 – FDA: Boston Scientific Corporation- Auriga 30 Laser System, Universal Part Number: M0068S30G0. Intended to be used in surgical; 29/03/2018 – Boston Scientific and Abbott have also recently unveiled new systems; 25/04/2018 – Boston Scientific Sees 2Q EPS 21c-EPS 23c; 03/04/2018 – Boston Scientific Expects Transaction to Be Immaterial to EPS, Adj EPS

Boston Partners, which manages about $53.18 billion and $86.06B US Long portfolio, decreased its stake in Marathon Oil Corp (NYSE:MRO) by 144,402 shares to 20.10 million shares, valued at $467.94 million in 2018Q3, according to the filing. It also reduced its holding in Foundation Bldg Matls Inc by 134,186 shares in the quarter, leaving it with 198,772 shares, and cut its stake in Kemper Corp Del (NYSE:KMPR).

Among 34 analysts covering Boston Scientific Corporation (NYSE:BSX), 29 have Buy rating, 0 Sell and 5 Hold. Therefore 85% are positive. Boston Scientific Corporation had 112 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Wednesday, January 17 by Canaccord Genuity. The company was initiated on Thursday, November 12 by Citigroup. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Needham on Thursday, February 1. The company was maintained on Thursday, August 31 by Needham. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Monday, July 10. RBC Capital Markets has “Buy” rating and $3100 target. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Buy” rating by Guggenheim on Thursday, June 9. The stock has “Buy” rating by SunTrust on Friday, December 1. Needham maintained it with “Buy” rating and $22 target in Wednesday, October 28 report. The rating was maintained by Needham on Wednesday, April 25 with “Buy”. As per Wednesday, November 29, the company rating was maintained by Canaccord Genuity.

Since August 15, 2018, it had 0 insider purchases, and 23 insider sales for $20.27 million activity. The insider Nanavaty Maulik sold $874,446. 1,500 shares were sold by Carruthers Wendy, worth $54,965. On Friday, November 9 Butcher Arthur C sold $154,000 worth of Boston Scientific Corporation (NYSE:BSX) or 4,000 shares. $145,692 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Ralls-Morrison Desiree on Wednesday, January 9. FUJIMORI YOSHIAKI had sold 6,143 shares worth $228,090. $495,954 worth of stock was sold by Ballinger Kevin J. on Thursday, January 3.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Seekingalpha.com which released: “Boston Scientific: Symetis Acquisition – Seeking Alpha” on March 30, 2017, also Streetinsider.com with their article: “Boston Scientific (BSX) on Watch Amid Chatter – StreetInsider.com” published on January 15, 2019, Seekingalpha.com published: “Boston Scientific beats by $0.01, misses on revenue – Seeking Alpha” on October 24, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Forbes.com and their article: “MedSurg Will Likely Drive Boston Scientific’s Near-Term Earnings Growth – Forbes” published on November 29, 2018 as well as Seekingalpha.com‘s news article titled: “Boston Scientific Channels Red Sox Winning Streak – Seeking Alpha” with publication date: November 07, 2018.

Investors sentiment increased to 1.22 in Q3 2018. Its up 0.02, from 1.2 in 2018Q2. It is positive, as 37 investors sold BSX shares while 189 reduced holdings. 101 funds opened positions while 174 raised stakes. 1.20 billion shares or 0.24% less from 1.21 billion shares in 2018Q2 were reported. Sumitomo Life Ins Com, a Japan-based fund reported 115,865 shares. 1.77 million were accumulated by Pictet Asset Ltd. Ubs Asset Mngmt Americas holds 4.10 million shares or 0% of its portfolio. Redwood Invs Lc reported 0.71% in Boston Scientific Corporation (NYSE:BSX). Lord Abbett Com Limited Liability accumulated 1.41M shares. Sit Inv Assocs, a Minnesota-based fund reported 144,660 shares. Natixis Advsrs Lp invested in 134,402 shares. Ardsley Advisory Prtn owns 12,500 shares. Envestnet Asset Management reported 6,240 shares. Optimum Inv Advsr holds 400 shares or 0% of its portfolio. Farmers And Merchants accumulated 0% or 1,005 shares. Trustmark National Bank Trust Department reported 11,123 shares. Aureus Asset Mngmt Limited Liability Corp has 632,298 shares for 3.1% of their portfolio. Tarbox Family Office holds 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 377 shares. Ima Wealth holds 1.77% or 117,815 shares in its portfolio.

Among 9 analysts covering Opus Bank (NASDAQ:OPB), 3 have Buy rating, 0 Sell and 6 Hold. Therefore 33% are positive. Opus Bank has $48 highest and $2200 lowest target. $37’s average target is 73.22% above currents $21.36 stock price. Opus Bank had 20 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, February 26 by Keefe Bruyette & Woods. Keefe Bruyette & Woods maintained Opus Bank (NASDAQ:OPB) on Friday, May 26 with “Hold” rating. As per Monday, July 10, the company rating was maintained by Piper Jaffray. The rating was downgraded by Keefe Bruyette & Woods to “Mkt Perform” on Tuesday, October 25. The firm has “Mkt Perform” rating by JMP Securities given on Friday, September 16. The firm earned “Outperform” rating on Wednesday, June 29 by Credit Suisse. The stock of Opus Bank (NASDAQ:OPB) earned “Hold” rating by Hovde Group on Tuesday, January 23. The firm has “Neutral” rating by JP Morgan given on Monday, January 30. Keefe Bruyette & Woods maintained it with “Hold” rating and $29.0 target in Thursday, December 21 report. PiperJaffray downgraded the shares of OPB in report on Tuesday, January 23 to “Neutral” rating.

More notable recent Opus Bank (NASDAQ:OPB) news were published by: Marketwatch.com which released: “Looking back 15 years, three things the dot-com bubble got right – MarketWatch” on January 07, 2015, also Businesswire.com with their article: “PENSCO Recognized as Alternative Asset Leader for Its Enhanced Alt-Navâ„¢ Technology at 2018 WealthManagement.com Awards – Business Wire” published on September 25, 2018, Seekingalpha.com published: “Bank OZK Leads Regional Banks Down – Seeking Alpha” on October 23, 2018. More interesting news about Opus Bank (NASDAQ:OPB) were released by: Nasdaq.com and their article: “Positive Revenue Surprises Lag Previous Quarter Levels – Nasdaq” published on April 20, 2018 as well as Seekingalpha.com‘s news article titled: “Tesla’s Unattractive Model X Presents Continuing Financial Risk – Seeking Alpha” with publication date: April 02, 2016.

Prospector Partners Llc, which manages about $2.43 billion and $724.33M US Long portfolio, upped its stake in Brinker Intl Inc (Put) (NYSE:EAT) by 90,000 shares to 96,000 shares, valued at $4.49M in 2018Q3, according to the filing. It also increased its holding in Brown & Brown Inc (NYSE:BRO) by 62,900 shares in the quarter, for a total of 1.01 million shares, and has risen its stake in Oritani Finl Corp Del (NASDAQ:ORIT).

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.